The following chart shows the leading innovators in Italian pharmaceuticals. Gilead leads the way with 135% growth, all of which comes from the hospitals sector.
written on 18.07.2016
Innovation & Growth in Italian Pharma
Similar Facts and Figures
Sources of R&D Investment in Italy
The below chart shows the sources of funding for R&D investment in Italy, with only 7% of total investment…
Italy Pharma Map
The following map shows the importance of the pharmaceutical industry to the highly regionalised Italian industry.…
Top Italian Pharma Companies
Italy’s pharma industry consistently ranks among the top 10 globally, with domestic companies making up a…
Italy / Life Sciences Industry Snapshot 2021
An overview of Italy’s pharma, biotech and medtech sectors by number of companies, production value, R&D…
Italy Pharma Industry Factsheet
The following chart gives the key statistics on the Italian pharmaceutical industry; from number of manufacturing…
Number of Clinical Trials in Italy
The following chart shows the number of clinical trials in Italy per year. Peaking in 2008 and slumping slightly…
China / Fosun Sales up 20%; MNC Price Manoeuvres Lead to Growth; Bayer Sees ‘Golden Age’ Ahead
The latest news from Chinese pharma, including Fosun Pharma’s 2021 interim results; how AstraZeneca, Bayer, Eli…
Ireland / Abbott Splashes the Cash on New R&D Investment; Bausch & Lomb Ramps Up Manufacturing Footprint; Looming Pricing Crisis
The latest news from Irish pharma, including a big new R&D investment for Abbott; contact lens giant Bausch…
China / Hong Chow Leaves Roche for Big New Role at Merck
In a big career move on a personal level and a sign of China’s continuing significance to global pharma, Hong…